The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://doi.org/10.25756/rpf.v12i1-2.239 |
Resumo: | With the outbreak of the pandemic associated with the new coronavirus (SARS-CoV-2) and the associated public health crisis, medical devices have assumed an absolute priority in preventing and combating SARS-CoV-2 in terms citizens’ health and safety.The dependence of the eastern markets, accentuated in recent years by an unregulated globalization, caused the shortage of different types of medical devices in the Portuguese market, which led to the mobilization of the competent national authorities, the academy and the national industry in the search for solutions.It is now important to define national strategies to support and develop this sector, which has proved to be of great importance for the Health System.The regulatory framework for medical devices is conditioned by Community Regulations and Directives, started in the 1980s, systematically adapted to the state of the art, with increasingly demanding requirements, establishing rules for technologies with importance in health gains, thus making an essential contribution health care for the benefit of citizens, contributing to investment in health and economic development.The synergy between the main Ministries involved, Ministry of Economy, Ministry of Science, Technology and Higher Education and Ministry of Health and National Industry, is essential to guarantee the transparency and trust of citizens, beneficiaries of the devices, essential to their security and welfare.It is important that the production activity of the national industry is in accordance with best practices and European legislation, as a guarantee of its compliance with safety and performance requirements and as a way of promoting international recognition and easy access to other markets. |
id |
RCAP_ec626ba2ded96c87a3b439cb75d2ca2b |
---|---|
oai_identifier_str |
oai:ojs.farmacoterapia.pt:article/282 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2A Importância dos Dispositivos Médicos na Prevenção e Combate ao SARS-CoV-2With the outbreak of the pandemic associated with the new coronavirus (SARS-CoV-2) and the associated public health crisis, medical devices have assumed an absolute priority in preventing and combating SARS-CoV-2 in terms citizens’ health and safety.The dependence of the eastern markets, accentuated in recent years by an unregulated globalization, caused the shortage of different types of medical devices in the Portuguese market, which led to the mobilization of the competent national authorities, the academy and the national industry in the search for solutions.It is now important to define national strategies to support and develop this sector, which has proved to be of great importance for the Health System.The regulatory framework for medical devices is conditioned by Community Regulations and Directives, started in the 1980s, systematically adapted to the state of the art, with increasingly demanding requirements, establishing rules for technologies with importance in health gains, thus making an essential contribution health care for the benefit of citizens, contributing to investment in health and economic development.The synergy between the main Ministries involved, Ministry of Economy, Ministry of Science, Technology and Higher Education and Ministry of Health and National Industry, is essential to guarantee the transparency and trust of citizens, beneficiaries of the devices, essential to their security and welfare.It is important that the production activity of the national industry is in accordance with best practices and European legislation, as a guarantee of its compliance with safety and performance requirements and as a way of promoting international recognition and easy access to other markets.Com o deflagrar da pandemia associada ao novo coronavírus (SARS-CoV-2) e à crise de saúde pública que lhe está associada, os dispositivos médicos, assumiram uma prioridade absoluta na prevenção e no combate ao SARS-CoV-2 em termos de saúde e segurança dos cidadãos. A dependência dos mercados do oriente, acentuada nos últimos anos por uma globalização desregulada, provocou a escassez de diversos tipos de dispositivos médicos no mercado português, o que levou à mobilização das autoridades competentes nacionais, da academia e da indústria nacional na procura de soluções.É importante agora definir estratégias nacionais para apoiar e desenvolver esse sector, que se revelou de grande importância para o Sistema de saúde.O quadro regulamentar dos dispositivos médicos é condicionado por Regulamentos e Diretivas comunitárias iniciado na década de 80, sistematicamente adaptados ao estado da arte, com requisitos cada vez mais exigentes, estabelecendo regras para tecnologias com importância nos ganhos em saúde, dando assim um contributo essencial para os cuidados de saúde em benefício dos cidadãos, contribuindo para o investimento em saúde e para o desenvolvimento económico.A sinergia entre os principais Ministérios envolvidos, Ministério da Economia, Ministério da Ciência, Tecnologia e Ensino Superior e Ministério da Saúde e a Indústria Nacional, é imprescindível para garantir a transparência e a confiança dos cidadãos, beneficiários dos dispositivos, essenciais à sua segurança e bem-estar.É importante que a atividade de produção da indústria nacional esteja de acordo com as melhores práticas e com a legislação europeia, enquanto garante da sua conformidade com os requisitos de segurança e desempenho e como forma de promover o reconhecimento internacional e o fácil acesso a outros mercados.Formifarma2020-07-21info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttps://doi.org/10.25756/rpf.v12i1-2.239https://doi.org/10.25756/rpf.v12i1-2.239Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 12 No 1-2 (2020): Janeiro/Fevereiro/Março e Abril/Maio/Junho; 39-47Revista Portuguesa de Farmacoterapia; v. 12 n. 1-2 (2020): Janeiro/Fevereiro/Março e Abril/Maio/Junho; 39-472183-73411647-354Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttp://revista.farmacoterapia.pt/index.php/rpf/article/view/282http://revista.farmacoterapia.pt/index.php/rpf/article/view/282/255Direitos de Autor (c) 2020 Revista Portuguesa de Farmacoterapiahttp://creativecommons.org/licenses/by-nc-nd/4.0info:eu-repo/semantics/openAccessPortugal de Abreu, Isabel Maria Martins2023-09-01T04:34:48Zoai:ojs.farmacoterapia.pt:article/282Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T15:11:41.356946Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 A Importância dos Dispositivos Médicos na Prevenção e Combate ao SARS-CoV-2 |
title |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 |
spellingShingle |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 Portugal de Abreu, Isabel Maria Martins |
title_short |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 |
title_full |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 |
title_fullStr |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 |
title_full_unstemmed |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 |
title_sort |
The Importance of Medical Devices in Preventing and Fighting SARS-CoV-2 |
author |
Portugal de Abreu, Isabel Maria Martins |
author_facet |
Portugal de Abreu, Isabel Maria Martins |
author_role |
author |
dc.contributor.author.fl_str_mv |
Portugal de Abreu, Isabel Maria Martins |
description |
With the outbreak of the pandemic associated with the new coronavirus (SARS-CoV-2) and the associated public health crisis, medical devices have assumed an absolute priority in preventing and combating SARS-CoV-2 in terms citizens’ health and safety.The dependence of the eastern markets, accentuated in recent years by an unregulated globalization, caused the shortage of different types of medical devices in the Portuguese market, which led to the mobilization of the competent national authorities, the academy and the national industry in the search for solutions.It is now important to define national strategies to support and develop this sector, which has proved to be of great importance for the Health System.The regulatory framework for medical devices is conditioned by Community Regulations and Directives, started in the 1980s, systematically adapted to the state of the art, with increasingly demanding requirements, establishing rules for technologies with importance in health gains, thus making an essential contribution health care for the benefit of citizens, contributing to investment in health and economic development.The synergy between the main Ministries involved, Ministry of Economy, Ministry of Science, Technology and Higher Education and Ministry of Health and National Industry, is essential to guarantee the transparency and trust of citizens, beneficiaries of the devices, essential to their security and welfare.It is important that the production activity of the national industry is in accordance with best practices and European legislation, as a guarantee of its compliance with safety and performance requirements and as a way of promoting international recognition and easy access to other markets. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-07-21 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://doi.org/10.25756/rpf.v12i1-2.239 https://doi.org/10.25756/rpf.v12i1-2.239 |
url |
https://doi.org/10.25756/rpf.v12i1-2.239 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
http://revista.farmacoterapia.pt/index.php/rpf/article/view/282 http://revista.farmacoterapia.pt/index.php/rpf/article/view/282/255 |
dc.rights.driver.fl_str_mv |
Direitos de Autor (c) 2020 Revista Portuguesa de Farmacoterapia http://creativecommons.org/licenses/by-nc-nd/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Direitos de Autor (c) 2020 Revista Portuguesa de Farmacoterapia http://creativecommons.org/licenses/by-nc-nd/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Formifarma |
publisher.none.fl_str_mv |
Formifarma |
dc.source.none.fl_str_mv |
Revista Portuguesa de Farmacoterapia / Portuguese Journal of Pharmacotherapy; Vol 12 No 1-2 (2020): Janeiro/Fevereiro/Março e Abril/Maio/Junho; 39-47 Revista Portuguesa de Farmacoterapia; v. 12 n. 1-2 (2020): Janeiro/Fevereiro/Março e Abril/Maio/Junho; 39-47 2183-7341 1647-354X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799129987008167936 |